Overview

Ph1 Marinol Interaction Study - Part 2 - 1

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant drug interactions before conducting outpatient studies.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Dronabinol